Bajaj Finserv Healthcare Growth Direct Plan
SIP amount
Min. ₹500
Lumpsum amount
Min. ₹500

Bajaj Finserv Healthcare Growth Direct Plan

NAV
₹9.6320
-0.31%
(24 Feb)
AUM
307 Cr
TER
0.74%
Risk
Very High Risk
Insights
Asset Under Management (AUM) is in the bottom 25% of comparable funds
Net Asset Value (NAV) is below its 200 days moving average
In beta. Send feedback here.
Compare with other fund
1Y
+31.2%
+30.0%
+29.8%
+25.8%
+9.0%
3Y
+36.0%
+33.8%
+33.2%
+32.6%
NA
5Y
+29.4%
+27.7%
+28.9%
NA
NA
ALL
+12.8%
+17.1%
+25.8%
+28.8%
-2.9%
VOL
20.0%
19.6%
21.8%
17.1%
13.5%
TER
0.8%
0.9%
0.6%
0.9%
0.7%
AUM
₹5,980 Cr
₹1,492 Cr
₹5,714 Cr
₹1,924 Cr
₹307 Cr
INFO
0.64
0.87
1.18
1.68
-0.22
See fund holdings as of 31st Jan
Top holdings
Divi's Laboratories Ltd
8.9%
Sun Pharmaceuticals Industries Ltd
7.9%
Apollo Hospitals Enterprise Ltd
6.2%
Aurobindo Pharma Ltd
6.0%
Piramal Pharma Ltd
4.0%
Emcure Pharmaceuticals Ltd
3.9%
Cipla Ltd
3.7%
Neuland Laboratories Ltd
3.6%
Fortis Healthcare Ltd
3.3%
Rubicon Research Ltd
3.3%
Top industry exposure
Healthcare
81.0%
Consumer Defensive
7.4%
Consumer Cyclical
2.1%
Basic Materials
1.5%
Other information
Minimum SIP
₹500
Minimum lumpsum
₹500
Additional lumpsum
₹100
Portfolio turnover
-
Lock-in period
-
Exit load
• 1% for redemption within 90 days
Fund objective
The objective of the Scheme is to generate long term capital appreciation by predominantly investing in equity and equity related securities of pharma, healthcare and allied companies.
Fund manager(s)
Nimesh Chandan
Siddharth Chaudhary
Sorbh Gupta

FAQs